Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1.75 ($0.02) and traded as high as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares.
Advanced Oncotherapy Price Performance
The firm’s 50-day moving average price is GBX 1.75 and its two-hundred day moving average price is GBX 1.75. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26. The firm has a market cap of £9.50 million, a PE ratio of -25.00 and a beta of 0.06.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Featured Articles
- Five stocks we like better than Advanced Oncotherapy
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- The How And Why of Investing in Oil Stocks
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
